AMRI expands Geographic Footprint and Market Share in Europe with purchase of Chemical Development/Large Scale Manufacturing Business

Pharma and biotech manufacturing services group Excelsyn has won the Queen’s Award for Enterprise 2009. The Award, in the International Trade category, recognizes a near-trebling of the company’s export earnings, with overseas business now accounting for 82% of sales.

Marking increased coverage of the US pharma outsourcing market, pharma and biotech services group Excelsyn has announced that Peter Chinigo will lead the Business Development drive in the USA.

Pharma and biotech services group Excelsyn has reported better-than-forecast sales and earnings for the first half of its 2008/09 financial year. Sales from its UK-based Molecular Development business in the six months to 30 November were US $10.98m., with an EBITDA of US $1.83m.

Pharma and biotech manufacturing services group Excelsyn has announced a series of moves reflecting two years of significant business growth – especially from customers in Asia and the USA.

Pharma and biotech services group Excelsyn reported sales of $28m and EBITDA of 7% on sales from its UK-based Molecular Development business for its financial 2007/08, ended 31 May. Sales were 43.5% ahead of comparable figures for 2006/07.

Excelsyn was announced Winner of the Welsh Exporter of the Year Award, sponsored by International Business Wales, at the Daily Post's Achievement Wales 2007 Business Awards on Friday 30th November.

Pharma and biotech services company, Excelsyn, has announced the appointment of Dr. Reg Shaw BSc, PhD as Non Executive Director.

Pharma and biotech services company, Excelsyn, has announced the appointment of CHEMGO Organica AG as its exclusive representative in the Swiss market.

Pharma intermediate and ingredient producers Excelsyn Molecular Development, of Holywell UK, has received a £350k Dti Spring Innovation Award to fund continuing research into new, high efficiency production routes for the synthesis of new pharmaceutical intermediates in collaboration with Bangor University, North Wales, UK.